News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sickle Cell Treatment Developed At LA BioMed Enters Phase 3 Clinical Trial


7/26/2010 7:03:12 AM

Medical News Today -- An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO have announced .

Read at EurekAlert!
Read at News-Medical
Read at Medical News Today


comments powered by Disqus
LA BioMed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES